NorthWest Biotherapeutics Inc (NWBO)

[alphapuppy]

Just got on the train to home from ASCO.

Yesterday the afternoon at the NWBO exhibit.

Attended the talk at the expert theater.

Was able to speak with AF for 10 minutes who was present at that meeting. I basically pushed back a little bit on his narrative as I think it’s important for him to receive some pushback heat given him some of the inaccuracies that he has Promoted.

His basic negative unfounded thesis was that the study was unblinded at the interim analysis and or at crossover so much so that the company knew the results and hence initiated the new endpoints.

I pushed back stating that for that to be true then all 65 ish Authors of the translational medicine article would be committing academic fraud because that journal article specifically states that at that time the data was Blinded. And asked him if he really believes that all those esteemed authors would all risk their reputations and be in on inaccurately reporting the blinded status for the article???

His response was that shareholders should ask the company if the data is so great then when are they going to file for approval?

Also was able to speak with Cofer and asked him when something is going to be done about all the lie’s people are promoting publicly against the company’s interests. He said “all in good time”. He was very positive about future events occur shortly.

Spoke with Linda Powers with Justin after the presentation And concur that she indicated that her father had passed away from Glioblastoma and that’s how she first became aware of this product. She also indicated that she’s certainly not doing this for the money given all of the crap that has been dished out towards that company. It did seem to be a passion of hers to see that this therapy be made available to all patients. So my takeaway is that any poster who says Linda is doing this just for the money or in anyway says Enron in the post is someone not to be trusted. Because I do not believe that is truthful at all regarding her motivations.

The talk, at the experts theater, while not being sexy, was very informative of how difficult manufacturing of this can be and how focused they are on achieving some automation in the process.

Also there was a good poster in the GBM poster session basically doing some groundwork saying that external controls is a legitimate methodology to compare treatments in diseases such as GPM.

Basically that’s my take on the ASCO meeting.

Longs stay strong. Journal will be forthcoming in my opinion shortly.